Search Results 1161-1170 of 19855 for Hepatitis b

1. Liver transplant - Doctors & Departments - Mayo Clinic

   Hepatitis B · Hepatitis C · Hepatocellular carcinoma (HCC) · Hilar cholangiocarcinoma · Liver cancer · Liver disease · Liver hemangioma · Living-donor liver ...

2. A Multi-Center Study Evaluating KTE-X19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia - Mayo Clinic

   Known infection with HIV, hepatitis B (HBsAg positive) or hepatitis C virus (anti-HCV positive); Presence of fungal, bacterial, viral, or other infection ...

3. Teplizumab-mzwv (intravenous route) - Side effects & uses - Mayo Clinic

   Haemophilus B Vaccine; Hepatitis A Vaccine, Inactivated; Hepatitis B Vaccine; Human Papillomavirus Vaccine; Influenza Virus Vaccine; Influenza Virus Vaccine ...

4. A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors - Mayo Clinic

   ... hepatitis B (HBV), or hepatitis C virus (HCV): a. Patients with HIV are excluded. a.b. Patients who are hepatitis B surface antigen positive are eligible if ...

5. A Study to Evaluate the Long-Term Effectives on ALS Disease Progression of BIIB067 - Mayo Clinic

   Current hepatitis B infection (defined as positive for hepatitis B surface antigen [HBsAg] and/or hepatitis B core antibody [HBcAb]). Participants with ...

6. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

   Ilyas, M.B.B.S.. Transplant Hepatologist. Rochester, MN. Areas of focus: Cholangiocarcinoma, Primary sclerosing cholangitis, Hepatitis C, Hepatitis B, ...

7. A Study of DFRF4539A in Patients with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Positive for hepatitis B, hepatitis C or HIV infection; Pregnant or lactating ... B. Contact information: Cancer Center Clinical Trials Referral Office.

8. TD-1473 for Active Ulcerative Colitis (UC) - Mayo Clinic

   ... hepatitis B surface antibody or detectable serum hepatitis B DNA. Has clinically significant abnormalities in laboratory evaluations; Participated in another ...

9. Deucravacitinib (oral route) - Side effects & dosage - Mayo Clinic

   Liver disease (eg, hepatitis B or C) or; Tuberculosis, history of—Use with caution. May make these conditions worse. Infection, active or; Liver disease ...

10. Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia - Mayo Clinic

    ... B Acute Lymphoblastic Leukemia ... Active viral or protozoal infection requiring IV treatment. Patients with known human immunodeficiency virus (HIV), hepatitis B ...